What is Brevibloc ?

Brevibloc, known generically as esmolol, is a short-acting beta-adrenergic antagonist primarily used for rapid heart rate control in conditions like supraventricular tachycardia and atrial fibrillation. Administered intravenously, it offers the advantage of quick onset and easy titration, providing effective management of acute cardiovascular conditions where precise heart rate regulation is necessary. Its unique pharmacokinetic profile allows it to be swiftly metabolized, minimizing prolonged effects and facilitating short-term therapeutic use.

• Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing
• Lightheadedness, dizziness, or fainting
• Confusion, weakness, numbness in your hands or feet
• Warmth or redness in your face, neck, arms, or upper chest
• Chest pain that may spread, trouble breathing, nausea, unusual sweating
• Swelling in your hands, ankles, or feet

• Chest pain that may spread, trouble breathing, nausea, unusual sweating
• Confusion, weakness, numbness in your hands or feet
• Lightheadedness, dizziness, or fainting
• Swelling in your hands, ankles, or feet
• Warmth or redness in your face, neck, arms, or upper chest
• Tell your doctor if you are pregnant or breastfeeding, or if you have heart or blood vessel disease, angina, heart failure, lung or breathing problems, diabetes, thyroid problems, or kidney disease.